Lessons from clinical trials on triple combination of immune checkpoint inhibitors and BRAF/MEK inhibitors in BRAF-mutant melanoma
@article{ATM112383,
author = {Takuya Maeda and Teruki Yanagi and Hideyuki Ujiie},
title = {Lessons from clinical trials on triple combination of immune checkpoint inhibitors and BRAF/MEK inhibitors in BRAF-mutant melanoma},
journal = {Annals of Translational Medicine},
volume = {11},
number = {9},
year = {2023},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/112383}
}